Semanteon Capital Management LP Makes New Investment in Phibro Animal Health Co. (NASDAQ:PAHC)

Semanteon Capital Management LP bought a new position in shares of Phibro Animal Health Co. (NASDAQ:PAHC) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 19,860 shares of the company’s stock, valued at approximately $417,000.

Several other institutional investors have also recently made changes to their positions in PAHC. Quantbot Technologies LP purchased a new stake in shares of Phibro Animal Health during the third quarter worth $70,000. New York State Teachers Retirement System lifted its position in shares of Phibro Animal Health by 16.7% during the fourth quarter. New York State Teachers Retirement System now owns 5,428 shares of the company’s stock worth $114,000 after acquiring an additional 775 shares in the last quarter. Amundi lifted its position in shares of Phibro Animal Health by 185.5% during the fourth quarter. Amundi now owns 9,855 shares of the company’s stock worth $212,000 after acquiring an additional 6,403 shares in the last quarter. Zacks Investment Management purchased a new stake in shares of Phibro Animal Health in the third quarter worth $274,000. Finally, SG Americas Securities LLC raised its position in shares of Phibro Animal Health by 7.4% in the fourth quarter. SG Americas Securities LLC now owns 13,162 shares of the company’s stock worth $276,000 after buying an additional 906 shares in the last quarter. Hedge funds and other institutional investors own 99.34% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on the company. StockNews.com upgraded Phibro Animal Health from a “hold” rating to a “buy” rating in a research report on Saturday, March 15th. Morgan Stanley increased their price objective on Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a research report on Tuesday, December 17th. Finally, Barclays increased their price objective on Phibro Animal Health from $20.00 to $22.00 and gave the stock an “underweight” rating in a research report on Monday, February 10th. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat.com, Phibro Animal Health currently has a consensus rating of “Hold” and a consensus price target of $21.00.

Phibro Animal Health Trading Up 0.4 %

NASDAQ PAHC opened at $21.90 on Friday. The stock’s 50-day simple moving average is $22.68 and its two-hundred day simple moving average is $22.59. Phibro Animal Health Co. has a twelve month low of $12.07 and a twelve month high of $26.55. The company has a quick ratio of 1.37, a current ratio of 3.20 and a debt-to-equity ratio of 2.99. The company has a market capitalization of $887.02 million, a price-to-earnings ratio of 45.63, a PEG ratio of 0.45 and a beta of 0.58.

Phibro Animal Health (NASDAQ:PAHC) last released its quarterly earnings results on Wednesday, February 5th. The company reported $0.54 earnings per share for the quarter, beating analysts’ consensus estimates of $0.40 by $0.14. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. Research analysts forecast that Phibro Animal Health Co. will post 1.95 EPS for the current fiscal year.

Phibro Animal Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Wednesday, March 5th will be given a dividend of $0.12 per share. The ex-dividend date is Wednesday, March 5th. This represents a $0.48 dividend on an annualized basis and a yield of 2.19%. Phibro Animal Health’s payout ratio is 100.00%.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.